General Archives - Page 5 of 20

A message from our new Chief Executive, Carolin Schumacher

2018-11-16

It is a great honour and pleasure for me to have been appointed as the new CEO of GALVmed. I join the organisation at a moment where GALVmed can look […]

Funding for Tryps Phase 3 approved

2018-11-15

GALVmed has received funding approval totalling to US$ 19 million for the Phase 3 programme on Improved Tools for the Control of Animal African Trypanosomosis (Tryps 3). The main objective […]

Peter Wells retires from GALVmed Board

2018-11-08

In September 2018 Dr Peter Wells retired from GALVmed’s Board of Trustees. Peter became involved with GALVmed initially through the Expert Scientific Advisory Committee before involvement in the governance of […]

Global network to eradicate PPR is launched

2018-04-19

GALVmed representatives Jeremy Salt and Mark Rweyemamu are this week attending a meeting in Vienna, Austria, to launch the Peste des petits ruminants Global Research and Expertise Network (PPR-GREN). The […]

International Research Consortium on Animal Health: March 2018 Newsletter

2018-03-15

Jeremy Salt, our Chief Scientific Officer attended two meetings highlighted in this March edition of STAR-IDAZ. Jeremy is a member of the scientific committee of International Research Consortium on Animal […]

GALVmed delivers goat rearing training in India

2017-08-30

GALVmed’s Market Development & Access (MD&A) department in South Asia has been working with the Jeevika Trust recently to deliver training in goat rearing in Bihar, India. The trust was aware of GALVmed’s […]

AgResults’ US $30 million Brucellosis Vaccine Prize on the agenda at Global Sheep Veterinary Congress

2017-05-26

Release date: 24 May 2017 EDINBURGH, UK, May 24, 2017 – Small ruminant experts attending this month’s International Sheep Veterinary Congress in Harrogate are being encouraged […]

OIE & GALVmed team up to promote harmonised registration of veterinary drugs in the SADC region

2017-05-23

(Johannesburg, 11 May 2017) In a globalising world where clusters of countries increasingly face the same challenges and seek closer cooperation to deal with these issues together, great gains can be […]

ViroVet and GALVmed to collaborate on novel vaccines for sheep & goats

2017-05-18

LEUVEN, Belgium, May 17th, 2017 — ViroVet NV, a leading Belgian biopharmaceutical company active in the development of innovative vaccines and antiviral drugs for livestock, is proud to announce a […]

Researchers on a mission to improve the East Coast Fever vaccine

2017-02-24

(15th February 2015) GALVmed recently held a workshop Nairobi (19-20 January 2017) to discuss ongoing research to improve the East Coast Fever (ECF) vaccine. The vaccine, commonly known as Infection […]